Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("OXAZEPAM")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 334

  • Page / 14
Export

Selection :

  • and

Simultaneous determination of N-butylscopolamine and oxazepam in pharmaceutical formulations by first-order digital derivative spectrophotometryINES TORAL, Maria; MUNOZ, Marcelo A; ORELLANA, Sandra L et al.Journal of AOAC International. 2005, Vol 88, Num 4, pp 1173-1178, issn 1060-3271, 6 p.Article

Analytical developments in toxicological investigation of drug-facilitated sexual assaultNEGRUSZ, Adam; GAENSSLEN, R. E.Analytical and bioanalytical chemistry. 2003, Vol 376, Num 8, pp 1192-1197, 6 p.Article

The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepamSMINK, Beitske E; HOFMAN, Berendina J. A; DIJKHUIZEN, Albert et al.British journal of clinical pharmacology. 2008, Vol 66, Num 4, pp 556-560, issn 0306-5251, 5 p.Article

Características físicas y propiedades de disolución de dispersiones sólidas de oxazepam con carbómero 934P = Physical characterization and dissolution properties of solid dispersions of the oxazepam with carbomer 934PMARIN, M. T; MARGARIT, M. V; ROSASCO, M. A et al.Ars Pharmaceutica. 2007, Vol 48, Num 3, pp 311-322, issn 0004-2927, 12 p.Article

Effects of additional oxazepam in long-term users of oxazepamVOSHAAR, Richard C; VERKES, Robbert-Jan; VAN LUIJTELAAR, Gilles L. J. M et al.Journal of clinical psychopharmacology. 2005, Vol 25, Num 1, pp 42-50, issn 0271-0749, 9 p.Article

Study on protolytic equilibria of lorazepam and oxazepam by UV and NMR spectroscopyPOPOVIC, G. V; SLADIC, D. M; STEFANOVIC, V. M et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 31, Num 4, pp 693-699, issn 0731-7085, 7 p.Article

Does a Medicinal Dose of Kava Impair Driving? A Randomized, Placebo-Controlled, Double-Blind StudySARRIS, J; LAPORTE, E; SCHOLEY, A et al.Traffic injury prevention (Print). 2013, Vol 14, Num 1-4, pp 13-17, issn 1538-9588, 5 p.Article

Enzyme-assisted synthesis and structural characterization of pure benzodiazepine glucuronide epimersPALLMANN, T; JONAS, U; WAGNER, M et al.European journal of pharmaceutical sciences. 2010, Vol 39, Num 4, pp 233-240, issn 0928-0987, 8 p.Article

Effects of oxazepam on methamphetamine-induced conditioned place preferenceGOEDERS, James E; GOEDERS, Nick E.Pharmacology, biochemistry and behavior. 2004, Vol 78, Num 1, pp 185-188, issn 0091-3057, 4 p.Article

Relationship between dissolution efficiency of Oxazepam/carrier blends and drug and carrier molecular descriptors using multivariate regression analysisCUTRIGNELLI, Annalisa; LOPEDOTA, Angela; TRAPANI, Adriana et al.International journal of pharmaceutics. 2008, Vol 358, Num 1-2, pp 60-68, issn 0378-5173, 9 p.Article

In vivo Evaluation of Substituted 3-Amino-1,4-benzodiazepines as Anti-depressant, Anxiolytic and Anti-nociceptive AgentsLATTMANN, Eric; LATTMANN, Pornthip; BOONPRAKOB, Yodchai et al.Arzneimittel-Forschung. 2009, Vol 59, Num 2, pp 61-71, issn 0004-4172, 11 p.Article

SPIROERGOMETRISCHE UNTERSUCHUNGEN AN GESUNDEN PROBANDEN UNTER OXAZEPAM-MEDIKATION = EXPLORATIONS SPIROERGOMETRIQUES CHEZ DES SUJETS SAINS RECEVANT DE L'OXAZEPAMKAIK G.1975; MUENCH. MED. WSCHR.; DTSCH.; DA. 1975; VOL. 117; NO 10; PP. 409-410; BIBL. 30 REF.Article

CONFLICT BEHAVIOR IN A HEATED-FLOOR MAZE: EFFECTS OF OXAZEPAM = COMPORTEMENT DANS UNE SITUATION CONFLICTUELLE DANS UN LABYRINTHE A SOL CHAUFFE: EFFETS DE L'OXAZEPAM1972; PSYCHOPHARMACOLOGIA; ALLEM.; DA. 1972; VOL. 26; NO 3; PP. 317-320; BIBL. 5REF.Serial Issue

ZUR UNTERSCHEIDUNG DER BENZODIAZEPINE LORAZEPAM UND OXAZEPAM MIT HILFE DER DUENNSCHICHTCHROMATOGRAPHISCHEN TRENNUNG-REAKTION-TRENNUNG-TECHNIK = LA DIFFERENCIATION DES BENZODIAZEPINES LORAZEPAM ET OXAZEPAM A L'AIDE DE LA SEPARATION PAR CHROMATOGRAPHIE EN COUCHE MINCESCHUETZ C; SCHUETZ H.1972; Z. KLIN. CHEM. KLIN. BIOCHEM.; DTSCH.; DA. 1972; VOL. 10; NO 11; PP. 528-530; ABS. ANGL.; BIBL. 19REF.Serial Issue

STEREOSELECTIVE LABELLING OF RACEMIC OXAZEPAM ACETATE AND ITS USE IN STUDYING STEREOSELECTIVE BINDING TO HUMAN SERUM ALBUMINSIMONYI M; FITOS I; TEGYEY Z et al.1980; J. CHEM. SOC., CHEM. COMMUN.; ISSN 0022-4936; GBR; DA. 1980; NO 23; PP. 1105-1106; BIBL. 7 REF.Article

DETERMINATION OF OXAZEPAM IN SERUM AND URINE BY ELECTRON CAPTURE GAS CHROMATOGRAPHY = DOSAGE DE L'OXAZEPAM DANS LE SERUM ET L'URINE PAR CHROMATOGRAPHIE EN PHASE GAZEUSE AVEC CAPTURE D'ELECTRONSVESSMAN J; FREIJ G; STROEMBERG S et al.1972; ACTA PHARM. SUECICA; SUEDE; DA. 1972; VOL. 9; NO 5; PP. 447-456; BIBL. 13REF.Serial Issue

RELATIONSHIP-BETWEEN CAMAZEPAM, N-METHYL-OXAZEPAM AND OXAZEPAM BRAIN CONCENTRATIONS AND ANTILEPTAZOL EFFECT IN THE RATCACCIA S; BALLABIO M; GARATTINI S et al.1981; J. PHARM. PHARMACOL.; ISSN 0022-3573; GBR; DA. 1981; VOL. 33; NO 3; PP. 185-187; BIBL. 7 REF.Article

THE DIFFERENTIAL EFFECTS OF CHLORDIAZEPOXIDE AND OXAZEPAM ON HOSTILITY IN A SMALL GROUP SETTING. = LES EFFETS DIFFERENTIELS DU CHLORDIAZEPOXYDE ET DE L'OXAZEPAM SUR L'HOSTILITE DANS UNE SITUATION DE PETIT GROUPEKOCHANSKY GE; SALZMAN C; SHADER RI et al.1975; AMER. J. PSYCHIATRY; U.S.A.; DA. 1975; VOL. 132; NO 8; PP. 861-863; BIBL. 18 REF.Article

WIRKUNG BEI OXAZEPAM (ADUMBRAN) AUF DEN INTRAOKULAREN DRUCK BEI LANGZEITTHERAPIE = L'EFFET DE L'OXAZEPAM (ADUMBRAN) SUR LA PRESSION OCULAIRE DANS LE TRAITEMENT DE LONGUE DUREEKASTNER W.1974; KLIN. MONATSBL. AUGENHEILKDE; DTSCH.; DA. 1974; VOL. 165; NO 6; PP. 946-947; ABS. ANGL.Article

L'OXAZEPAM EN PSYCHIATRIEBATIER D.1972; PSYCHOL. MED.; FR.; DA. 1972; VOL. 4; NO 3; PP. 497-502; ABS. ANGL.; BIBL. 11REF.Serial Issue

CLINICA E TERAPIA DEI DISTURBI DA MENOPAUSA. SULL'USO TERAPEUTICO DI UNA ASSOCIAZIONE FARMACOLOGICA ESTROGENI CONIUGATI-OXAZEPAM = CLINIQUE ET TRAITEMENT DES TROUBLES DE LA MENOPAUSE. SUR L'EMPLOI THERAPEUTIQUE D'UNE ASSOCIATION PHARMACOLOGIQUE OESTROGENES CONJUGUES-OXAZEPAMGIAQUINTO M; TCHAPRASSIAN J; FOTI A et al.1969; ATTUAL. OSTETR. GINECOL.; ITAL.; DA. 1969; VOL. 15; NO 3; PP. 185-221; BIBL. 2 P.Article

Evidence for oxazepam as in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletionXI HE; HESSE, Leah M; HAZARIKA, Suwagmani et al.British journal of clinical pharmacology. 2009, Vol 68, Num 5, pp 721-730, issn 0306-5251, 10 p.Article

SAFETY OF OXAZEPAM.SOLOMON K.1978; NEW YORK STATE J. MED.; U.S.A.; DA. 1978; VOL. 78; NO 1; PP. 91-92; BIBL. 11 REF.Article

ESSAI CLINIQUE DE L'OXAZEPAM. A PROPOS DE 32 OBSERVATIONS1972; ; S.L.; DA. 1972; PP. (68 P.); BIBL. 7 P.; (THESE DOCT. MED.; UNIV. CLAUDE BERNARD LYON; 1972)Thesis

ESSAI COMPARATIF AMBULATOIRE DU RO5-3350 (LEXOTANIL) ET DE L'OXAZEPAMLADAME FG.1974; PRAXIS; SCHWEIZ; DA. 1974; VOL. 63; NO 33; PP. 1005-1008; ABS. ANGL.Article

  • Page / 14